Abstract 2042P
Background
Breast cancer is the most diagnosed cancer affecting Australian women. While the incidence rate of breast cancer is lower in indigenous women than non-indigenous women the mortality rate is higher, with indigenous women 1.2 times more likely to die from the disease. The are many factors that contribute to this and if we want outcomes to improve for indigenous women with breast cancer, we must identify where practice and policy can change and improve. These findings may inform approaches for indigenous women in other high-income countries who experience similarly poor breast cancer outcomes.
Methods
This research employed the Context-Mechanism-Outcome (CMO) framework to reveal potential mechanisms and contextual factors that influence breast cancer outcomes for indigenous women. The framework explains generative causation, which helps to highlight the relationship between a context, mechanism, and outcome of a program or policy. The mechanisms and contextual factors were stratified into multiple levels; micro (interpersonal), meso (systemic), and macro (policy) levels. “If-Then-Because” statements were used to represent (broadly) the elements of CMO.
Results
The CMO framework allowed us to interpret evidence regarding indigenous women and breast cancer and provided nine practical ways to improve health outcomes and survival rates: 1. Improved health literacy regarding the importance of screening and early detection, delivered in a culturally safe way 2. Increased cultural safety and access to screening services 3. Presence of indigenous health service providers 4. Ensuring health service provider is local and/or familiar with indigenous culture and community 5. Culturally safe screening, diagnosis, treatment and follow-up settings 6. Local indigenous screening champions in the community 7. Protocols for abnormal results are tailored to local setting and community 8. Culturally safe support available for people who receive diagnoses 9. Policy is re-written in consultation with indigenous people and provides solutions to improve health outcomes.
Conclusions
Using the CMO framework, this study has provided nine practical measures to assist in improving the health outcomes for Australian indigenous women with breast cancer.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
V. Christie.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
2066P - Evaluation of the quality and reliability of ChatGPT and Perplexity's responses about rectal cancer
Presenter: Ozan Yazici
Session: Poster session 06
2067P - Influence of psychiatric disorders on survival in patients with lung cancer: Real-world data
Presenter: Tomi Kovacevic
Session: Poster session 06
2068P - Perspectives and concerns on sexuality among adolescents and young adults treated for testicular germ cell tumour: The PRICELESS-study - A qualitative study
Presenter: Danielle Zweers
Session: Poster session 06
2069P - QoL changes of caregivers during first-line palliative chemotherapy for patients with incurable cancer
Presenter: Nobumichi Takeuchi
Session: Poster session 06
2070P - Assessment of healthy lifestyle habits in breast cancer patients
Presenter: Juan Cristobal Sanchez
Session: Poster session 06
2071P - Identification of top issues and concerns of cancer patients in Korea on social media
Presenter: Joo Han Lim
Session: Poster session 06
2072P - Topical application of mixed agents to reduce oral mucositis during radiotherapy in post operated head and neck cancer
Presenter: Chandra Prakash
Session: Poster session 06
2073P - Medical cannabis: A potential effective treatment for chemotherapy-induced peripheral neuropathy (CIPN)
Presenter: Ravit Geva
Session: Poster session 06
2074P - Oral cannabidiol for prevention of chemotherapy-induced peripheral neuropathy
Presenter: Sebastian Nielsen
Session: Poster session 06